You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


A New Path Forward? Where Are We Going in Managing Hypoparathyroidism?

  • Authors: Aliya Khan, MD, FRCPC, FACP, FACE
  • CME Released: 4/29/2021
  • Valid for credit through: 4/29/2022
Start Activity

Target Audience and Goal Statement

This activity is intended for diabetologists & endocrinologists and primary care physicians.

The goal of this activity is to educate endocrinologists and others who treat hypoparathyroidism about new/emerging options for management.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Current state of the art and gaps in management of hypoparathyroidism
    • Emerging treatments for the management of hypoparathyroidism


As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Aliya Khan, MD, FRCPC, FACP, FACE

    Professor of Clinical Medicine
    Divisions Endocrinology and Metabolism and Geriatrics
    Director, Fellowship in Metabolic Bone Disease
    Director, Calcium Disorders Clinic
    McMaster University
    Hamilton, Ontario, Canada


    Disclosure: Aliya Khan, MD, FRCPC, FACP, FACE, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Alexion Pharmaceuticals, Inc.; Amgen Inc.; Amolyt; Takeda; Ultragenyx
    Served as a speaker or a member of a speakers bureau for: Alexion Pharmaceuticals, Inc.; Amgen Inc.; Ultragenyx
    Received grants for clinical research from: Alexion Pharmaceuticals, Inc.; Amgen Inc.; Ascendis Pharma; Radius Health, Inc.; Takeda; Ultragenyx


  • Anne G. Le, PharmD

    Senior Medical Education Director, Medscape, LLC 


    Disclosure: Anne G. Le, PharmD, has disclosed no relevant financial relationships.

Content Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

The following SPC member who planned and reviewed content for this activity reported the following relevant financial relationships:   

Kelly Lauter Roszko, MD, PhD:
The National Institute of Dental and Craniofacial Research (NIDCR) receives financial support from Calcilytix and Amgen for research investigating pharmaceutical agents.
I am an unpaid consultant to Bayer and Calcilytix.

The following SPC Committee members reported financial relationships:

Andjela T. Drincic, MDAdvisory Board Member, Corcept

Angela M. Leung, MDSpeaker, Medical Education Resources, MCE Conferences, ATA Board Member

Amy Rothberg, MDSpouse, consultant of Merck

Katherine Araque, MDSpeaker, Novo Nordisk; Advisory Board, Corcept

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:

Beret Ann Casey, MD; Lorena Alarcon-Casas Wright, MD; Neena Natt, MD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

The staff involved in the development of this CME activity reported no relevant financial relationships

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

Developed through a collaboration between the Endocrine Society and Medscape Education.

As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this CME activity.

    For Physicians

  • The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved accreditation with commendation.

    The Endocrine Society designates this online activity for a maximum of 0.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


A New Path Forward? Where Are We Going in Managing Hypoparathyroidism?

Authors: Aliya Khan, MD, FRCPC, FACP, FACEFaculty and Disclosures

CME Released: 4/29/2021

Valid for credit through: 4/29/2022




  • Print